Kyle Gavulic

Kyle A. Gavulic was born in Flint, MI and raised in the small neighboring town of Goodrich. He holds a Bachelor of Arts in French and in Medicine, Health, and Society with a concentration in health economies and policies from Vanderbilt University. Prior to affiliating with Yale, Kyle served as a Health Policy Services Analyst in the Department of Health Policy in the Vanderbilt School of Medicine. In this capacity, he conducted quantitative health services research under the supervision of Dr. Stacie Dusetzina, focusing on high-cost prescription drugs and the Food and Drug Administration’s accelerated approval pathway. Kyle was also a teaching and research assistant to Dr. Melinda Buntin. From July 2020 to May 2022, Kyle also served as Editorial Intern of JAMA Health Forum.

Kyle is now a MD-PhD candidate at Yale planning to pursue a PhD in Health Policy and Management. His research interests include access to and coverage of high-cost prescription medications, LGBTQ health, access to care and health outcomes for underserved populations, financial burden of health care spending, non-medical determinants of health, comparative health systems, and diversity of the physician workforce. His research in LGBTQ health disparities with Dr. Gilbert Gonzales and in U.S. prescription drug policy with Dr. Stacie Dusetzina has led to publications in the American Journal of Public Health, JAMA Internal Medicine, JAMA Health Forum, Journal of Adolescent Health, and Medical Care Research and Review. He serves as co-leader of Yale School of Medicine's Chapter of the American Medical Student Association (AMSA), a mentor in the Program to Advance Training in Health & Sciences (PATHS), and a member of the MD/PhD Diversity & Inclusion Committee.